12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Vpriv velaglucerase alfa regulatory update

The Scottish Medicines Consortium recommended the use of Shire's Vpriv velaglucerase alfa on the National Health Service (NHS) in Scotland to treat...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >